- Home
- SPRY vs TXG Comparison
SPRY vs TXG Comparison
Compare SPRY & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- TXG
- Stock Information
- Founded
- SPRY 2015
- TXG 2012
- Country
- SPRY United States
- TXG United States
- Employees
- SPRY N/A
- TXG 1306
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- TXG Biotechnology: Laboratory Analytical Instruments
- Sector
- SPRY Health Care
- TXG Industrials
- Exchange
- SPRY Nasdaq
- TXG Nasdaq
- Market Cap
- SPRY 1.4B
- TXG 1.3B
- IPO Year
- SPRY N/A
- TXG 2019
- Fundamental
- Price
- SPRY $15.69
- TXG $10.81
- Analyst Decision
- SPRY Strong Buy
- TXG Buy
- Analyst Count
- SPRY 4
- TXG 15
- Target Price
- SPRY $28.75
- TXG $15.81
- AVG Volume (30 Days)
- SPRY 1.2M
- TXG 3.7M
- Earning Date
- SPRY 08-05-2025
- TXG 08-07-2025
- Dividend Yield
- SPRY N/A
- TXG N/A
- EPS Growth
- SPRY N/A
- TXG N/A
- EPS
- SPRY N/A
- TXG N/A
- Revenue
- SPRY $97,122,000.00
- TXG $624,662,000.00
- Revenue This Year
- SPRY N/A
- TXG N/A
- Revenue Next Year
- SPRY $140.40
- TXG $5.70
- P/E Ratio
- SPRY N/A
- TXG N/A
- Revenue Growth
- SPRY 971120.00
- TXG N/A
- 52 Week Low
- SPRY $7.55
- TXG $6.78
- 52 Week High
- SPRY $18.51
- TXG $24.76
- Technical
- Relative Strength Index (RSI)
- SPRY 60.81
- TXG 62.32
- Support Level
- SPRY $14.77
- TXG $10.38
- Resistance Level
- SPRY $16.23
- TXG $11.10
- Average True Range (ATR)
- SPRY 0.73
- TXG 0.57
- MACD
- SPRY 0.12
- TXG 0.10
- Stochastic Oscillator
- SPRY 84.68
- TXG 83.45
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).